STOCK TITAN

CTI BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, Apr. 14

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CTI BioPharma Corp. (NASDAQ: CTIC) will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on April 14, 2021, at 3:00 p.m. EST. The event will be conducted virtually and the presentation will be available for live webcast and replay on the company's website. CTI BioPharma focuses on developing targeted therapies for blood-related cancers, with a key focus on pacritinib, their candidate in late-stage development for myelofibrosis and severe COVID-19. The company is headquartered in Seattle, Washington.

Positive
  • None.
Negative
  • None.

SEATTLE, April 7, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at 3:00 p.m. EST. The conference will be held in a virtual meeting format.

Presentation details:

Event: 20th Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 14, 2021
Time: 3:00 p.m. EST

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.

We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts:

Maghan Meyers

+212-600-1902

cti@argotpartners.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-on-wednesday-apr-14-301263743.html

SOURCE CTI BioPharma Corp.

FAQ

When is CTI BioPharma's presentation at the Needham Conference?

CTI BioPharma will present at the Needham Virtual Healthcare Conference on April 14, 2021, at 3:00 p.m. EST.

What is the focus of CTI BioPharma's research and development?

CTI BioPharma focuses on developing targeted therapies for blood-related cancers, particularly myelofibrosis and severe COVID-19.

Where can I watch CTI BioPharma's conference presentation?

The presentation will be webcast live and available for replay on the Investors section of CTI BioPharma's website.

What product candidate is CTI BioPharma currently developing?

CTI BioPharma is currently developing pacritinib, which is in late-stage development for myelofibrosis.

What time does CTI BioPharma's presentation start?

The presentation starts at 3:00 p.m. EST.

CTIC

NASDAQ:CTIC

CTIC Rankings

CTIC Latest News

CTIC Stock Data

1.20B
123.11M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Seattle